Last reviewed 2023-02-08 · How we verify
Home › Trials › NCT04535310
NCT04535310
Wear Experience With Daily Contact Lenses Over a Long Day
On this page:
Summary Quick facts Who can join Endpoints Results Publications Related trials Sources
Completed
NA
Results posted
Last updated 8 February 2023
What this trial tests
NA trial testing Precision1® Daily Disposable Contact Lens in Contact Lens in 35 participants. Completed in 31 March 2021.
Timeline
13 October 2020
Primary endpoint 8 December 2020
31 March 2021
Quick facts
Lead sponsor Ohio State University
Phase NA
Status Completed
Study type INTERVENTIONAL
Allocation na
Design single group
Masking none
Primary purpose treatment
Enrollment 35
Start date 13 October 2020
Primary completion 8 December 2020
Estimated completion 31 March 2021
Sites 1 location across United States
Drugs / interventions tested
Precision1® Daily Disposable Contact Lens
Conditions studied
Sponsor
Ohio State University
Who can join
Adults 18 to 40, any sex, with Contact Lens. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Subjective Overall Comfort as Assessed Using the Visual Analog Scale (VAS)
Primary
· Up to 14 days
Subjective overall comfort as assessed using the Visual Analog Scale (VAS), with a scale of 0 to 100 with 0 being poor and 100 being excellent.
Group Value 95% CI Daily Disposable Contact Lens 93 82.5 – 99
Sponsor's own description
This study is evaluating the wear experience of a daily contact lens after 10, 12, 14, and 16 hours of lens wear.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Long Day Wear Experience with Water Surface Daily Disposable Contact Lenses.
Fogt JS, Patton K. ·
· 2022
· cited 8×
· PMID 35860307
· DOI 10.2147/opto.s367891
Verify or expand the search:
Other trials of Precision1® Daily Disposable Contact Lens
Trials testing the same drug.
NCT05096156 — Evaluation of Wear Experience With Daily Contact Lenses
· NA
· completed
Other Ohio State University trials
Trials by the same sponsor.
NCT06542458 — Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog
· not yet recruiting
NCT07217548 — Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease Patients
· NA
· enrolling by invitation
NCT07215221 — Implementation of TBI-RECOVER in Substance Use Treatment
· NA
· not yet recruiting
NCT07278427 — Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START
· recruiting
NCT07490444 — Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome
· Phase 2
· not yet recruiting
Verify against primary sources
Data sources for this page
Trial protocol + status : ClinicalTrials.gov NCT04535310 (US National Library of Medicine, public domain)
Publications : Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links : matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor : as reported to ClinicalTrials.gov by Ohio State University
Last refreshed : 8 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04535310.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing
Not medical advice. Information on this page is collated from primary regulatory and clinical-trial sources for research purposes. It is not a substitute for consultation with a licensed healthcare professional. See our editorial policy for sourcing and methodology.